Global HealthX Crosses $15 Mn in Healthcare Investments, Unveils Startup Cohort
Global HealthX, the venture studio of the Global University Foundation, announced it has surpassed $15 million in investments across Indian healthcare and life‑science startups over the past two years. The latest cohort features five companies—TapHealth, Wellytics, Monitra Health, Merry Health and Avika—focused on AI‑driven chronic care, cardiac monitoring, emergency response, genomics‑based precision medicine, and VR mental‑health therapy. GHX typically invests $250,000‑$500,000 per startup and remains flexible for follow‑on rounds. In 2026 it aims to allocate an additional $8‑10 million to ten new ventures, deepening its role in building scalable health infrastructure.
FDA Policy Tracker 2026: Priority Vouchers Questioned, PRVs Return
2026 regulatory landscape sees the FDA reviving the rare‑pediatric disease priority review voucher (PRV) program, launching the PreCheck manufacturing pilot, and issuing new guidance for multiple myeloma trials and GLP‑1 label warnings. The PRV reinstatement restores a $150 million voucher market,...
Cerebellar Microglia-Derived IL-17A Mitigates Autism-Related Behavioral and Synaptic Deficits
Researchers discovered that cerebellar microglia are the sole source of elevated interleukin‑17A (IL‑17A) in a Fragile X mouse model of autism. The microglia‑derived IL‑17A restores Purkinje cell firing rates and normalizes synaptic inhibition, leading to improved social interaction and reduced...
The Many-to-Many Problem of Endophenotypes in Psychiatry - a Biological Perspective
The article argues that current psychiatric diagnostic systems and neuroimaging endophenotypes fail to capture the underlying biological complexity of mental illness. Genetic studies reveal extensive pleiotropy and overlapping risk loci across disorders, while neurotransmitter systems exhibit strong spatial colocalization, creating...
Correction: Microbiota Is Essential for Social Development in the Mouse
A correction notice was issued for the Molecular Psychiatry article that originally linked gut microbiota to social development in mice. The wrong image was published as Figure 1a and has now been replaced with the correct visual, while Figure 1b and the...
Circuit-Informed Modulation of Traumatic Memory in PTSD: Integrating Extinction, Suppression, and Reconsolidation
A new review synthesizes recent circuit‑level findings to propose an integrated model for modulating traumatic memories in PTSD. It combines extinction, memory suppression, and reconsolidation mechanisms, emphasizing the amygdala‑prefrontal‑hippocampal network and its neuromodulatory inputs. The authors highlight how this framework...
GLP-1s Are an Environmental Catastrophe
GLP‑1 agonists such as Ozempic have surged in popularity for weight loss, but their peptide‑based manufacturing generates massive environmental waste. Current solid‑phase peptide synthesis (SPPS) relies on toxic organic solvents, producing over 123 million pounds of waste annually for semaglutide alone....
ByteDance Releases Protenix-V1: A New Open-Source Model Achieving AF3-Level Performance in Biomolecular Structure Prediction
ByteDance unveiled Protenix‑v1, an open‑source, AlphaFold3‑style foundation model for all‑atom biomolecular structure prediction covering proteins, nucleic acids and ligands. The 368 million‑parameter system matches AlphaFold3’s training data cutoff, model scale and inference budget, and claims superior performance on curated benchmarks. Protenix...
India Has Changed Its Startup Rules for Deep Tech
India has overhauled its startup framework, extending deep‑tech status to 20 years and raising the revenue eligibility threshold to ₹3 billion. The change dovetails with a ₹1 trillion Research, Development and Innovation fund and the $1 billion‑plus India Deep Tech Alliance, aimed at easing...
SpaceX Crew-12 Will Study How Microgravity Affects the Human Body
NASA’s Crew‑12 mission will launch aboard SpaceX’s Crew Dragon on Feb. 11, carrying two NASA astronauts, an ESA specialist, and a Russian cosmonaut. While aboard the ISS, the crew will conduct the Venous Flow study to assess blood‑clot risk and a...
#ACTRIMS26: Sanofi Unpacks Data From a Failed Phase 3 Tolebrutinib Trial in PPMS
Sanofi disclosed results from its Phase 3 trial of the BTK inhibitor tolebrutinib in primary progressive multiple sclerosis (PPMS). The study failed to meet its primary endpoint of slowing disability progression, and secondary outcomes showed no meaningful benefit. Safety data...
Exposure to Grilled Lamb‐Borne Carbon Quantum Dots Induces Intrahepatic Cholestasis by Activating the Intestinal Microbial‐Derived Lipopolysaccharide‐TLR4 Pathway
Researchers discovered that carbon quantum dots (CQDs) released from grilled lamb accumulate in mice after nine weeks of oral exposure at 25 mg kg⁻¹, damaging liver and intestinal barriers. The CQDs elevate gut‑derived lipopolysaccharide, triggering the intestinal LPS‑TLR4‑MyD88 signaling cascade and hepatic...
Advanced Photoporation: Micro‐Nanostructures for Size‐Specific Highly Efficient Biomolecular Delivery
Photoporation is emerging as a versatile, non‑viral platform for intracellular delivery, and a new review proposes a size‑centric framework that categorises strategies by cargo dimensions rather than by laser or material type. The authors analyse how micro‑ and nanostructured substrates...
Biocompatible Glue‐Enabled Drug Localization and Mechanical Reinforcement of Lyophilized Microneedle Systems
The Lyophilized Microneedle System with Biocompatible Glue (LMS‑BG) integrates a porous, drug‑loaded microneedle tip with a biodegradable ethanol‑based glue to create a mechanically robust, ultra‑fast dissolving transdermal platform. In tests using lidocaine, the system dissolved 11‑times faster than conventional dissolving...
Dynamically Reprograms Mitochondrial Respiration to Augment Cuproptosis in Cancer Therapy
Researchers engineered a copper‑coordinated polymer that transports lactate oxidase into cancer cells, converting intracellular lactate to pyruvate. This metabolic shift elevates mitochondrial respiration, sensitizing tumors to copper‑driven cuproptosis. Simultaneously, copper triggers DLAT oligomerization and a Fenton‑like reaction, inducing ferroptosis. In...
NBD Integrated and Vitamin B6‐Driven Charge‐Reversible Peptide‐Based Nanocarriers for Targeted Therapeutic Delivery
Researchers have engineered a phenylalanine‑tryptophan dipeptide nanocarrier functionalized with the fluorescent probe NBD and a vitamin B6‑derived pH‑responsive unit. The self‑assembled nanospheres load doxorubicin with high efficiency and undergo charge reversal at mildly acidic pH, triggering rapid drug release and nuclear...
Dual Therapeutic Effects of Ultra‐Small Platinum‐Selenium Nanoparticles on Oxalate‐Induced Acute Kidney Injury
Researchers synthesized ultra‑small platinum‑selenium (Pt‑Se) nanoparticles that effectively halt calcium oxalate (CaOx) crystal nucleation and growth, reducing crystal‑cell interactions and oxidative damage. In vitro assays demonstrated strong inhibition of CaOx crystallization, while a hyperoxaluria mouse model showed markedly lower renal...
Fluorescently Labeled Gradient Hydrogels Reveal Matrix‐Dependent Cell Responses to Substrate Stiffness
Researchers introduced a thermophoresis-based method to fabricate fluorescently labeled stiffness gradient hydrogels, enabling contactless stiffness mapping via standard microscopy. The technique leverages fluorescein isothiocyanate labeling, where fluorescence intensity reflects polymer concentration and thus stiffness. Experiments with gelatin methacryloyl (GelMA) and...
'A Second Set of Eyes': AI-Supported Breast Cancer Screening Spots More Cancers Earlier, Landmark Trial Finds
A prospective, population‑based MASAI trial in Sweden screened over 100,000 women using a commercially available AI system alongside radiologists. The AI‑assisted workflow identified more clinically relevant breast cancers and cut interval‑cancer rates without raising false‑positive alerts. Radiologists read AI‑flagged cases...
Scientists Identify SARS-CoV-2 PLpro and RIPK1 Inhibitors Showing Potent Synergistic Antiviral Effects in Mouse COVID-19 Model
Scientists have identified two small‑molecule inhibitors—SHY1643 targeting the SARS‑CoV‑2 papain‑like protease (PLpro) and QY1892 targeting the host kinase RIPK1—that together produce a potent antiviral effect in a mouse COVID‑19 model. Individually, each compound modestly reduced viral loads and inflammation, but...
McKinsey Vet Franck Le Deu Joins Nisa Leung’s New Fund; Plus C-Suite Shuffle at Bicycle
Former McKinsey senior partner emeritus Franck Le Deu has joined Aulis Capital as a venture partner. Aulis, the Hong Kong‑based fund launched by veteran Chinese VC Nisa Le Ung, will back emerging biotech and health‑tech companies across Asia and the West. Le Deu, who...
Multidisciplinary Evidence-Based Guidelines for Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease
A new multidisciplinary, evidence‑based guideline set recommends therapeutic drug monitoring (TDM) for biologic therapies in inflammatory bowel disease (IBD). The recommendations integrate pharmacokinetic data, disease activity metrics, and patient‑specific factors to optimize dosing of anti‑TNF, anti‑integrin, and anti‑IL agents. The...
Series A Companies: Biotech’s Class of 2025
After four years of falling series A activity, biotech start‑up financing stabilized in 2025. The number of companies raising series A remained flat versus 2024, while total dollars raised increased. BioCentury’s analysis shows a broader revival, with round sizes, investor profiles, and...
Structure-Guided Development of Picomolar Macrocyclic Inhibitors Targeting TRPC5 Channels with Antidepressant Effects
Scientists have created a new class of macrocyclic inhibitors that target the TRPC5 ion channel with picomolar potency. The lead compound JDIC‑127 achieves an IC₅₀ of 374 pM, roughly 200‑fold more potent than the previous benchmark HC‑070, and demonstrates high selectivity...
Circulating Mitochondrial and Cellular Damage Markers in Long COVID: Links to Cognitive Function, Psychological Distress, and Inflammation
A recent Molecular Psychiatry study measured circulating mitochondrial DNA and other cellular damage markers in individuals with long COVID and found them significantly elevated compared with recovered controls. The analysis revealed strong correlations between higher mtDNA levels and reduced performance...
US Calls for DOJ Investigation of Hims over GLP-1 Drugs
The U.S. government has referred tele‑health firm Hims & Hers to the Department of Justice for a formal investigation into its GLP‑1 weight‑loss program. Hims, which recently launched a compounded version of GLP‑1 drugs to compete with Novo Nordisk’s market‑leading injectables, is...
Sanofi Misses in Fabry: Is It Time to Move on From GCS Inhibition in the Indication?
Sanofi announced that its glucosylceramide synthase (GCS) inhibitor for Fabry disease failed to meet the primary efficacy endpoint in a late‑stage trial. The double‑blind study enrolled roughly 280 patients and showed no statistically significant improvement in key renal or cardiac...
Study Reveals Modulated UV-C Light Extends Guava Shelf Life
A recent study demonstrates that applying modulated UV‑C light to harvested guavas can significantly prolong their shelf life. The researchers found that pulsed UV‑C treatment suppresses microbial growth while using roughly 30% less energy than continuous exposure. Shelf life extensions...
TrumpRx Launch Falls Flat for some, Citing Generic Access
President Donald Trump unveiled TrumpRx, a direct‑to‑consumer drug platform promising to let Americans purchase prescription medicines without traditional insurance intermediaries. The rollout was framed as a fulfillment of broken political promises to lower drug costs. However, early feedback highlights that...
New Discovery Reveals Why Ovarian Cancer Spreads Rapidly in the Abdomen
Recent research highlights AI‑driven discovery of tetrahydrocarbazoles as click‑activated, broad‑spectrum antitumor agents, while a plant‑derived limonoid, DHL‑11, targets IMPDH2 to inhibit triple‑negative breast cancer. A U.S. survey shows patients still favor in‑clinic cervical cancer screening over home tests, and a...
New Study Uncovers Mechanism Behind Burn Pit Particulate Matter–Induced Lung Inflammation
Researchers at National Jewish Health published a study showing that particulate matter from military burn pits provokes markedly stronger inflammatory and oxidative responses in lung macrophages than ordinary desert dust. The work identifies Toll‑like Receptor 2 (TLR2) as the primary sensor...
HHS Drops Legal Fight over Blocked 340B Rebate Pilot
The U.S. Department of Health and Human Services has abandoned its legal challenge to a federal court’s injunction that halted a proposed 340B drug‑price rebate pilot. The pilot, designed by the Trump administration to test new rebate mechanisms for hospitals...
Orphan Drug Tweak in US Spending Bill Will Make Life Easier for the FDA
President Donald Trump signed the federal spending bill preserving the FDA’s ability to grant a seven‑year exclusivity period for orphan drugs that receive new indications. The provision reverses earlier suggestions to shorten the exclusivity term, embedding the policy in the...
Study Strengthens the Potential of Mycoprotein as an Alternative to Meat
A doctoral thesis from the University of Borås demonstrates that mycoprotein is digested as efficiently as chicken and fish, with amino acid profiles meeting human nutritional needs. Simulated INFOGEST digestion revealed iron is more bioavailable because mycoprotein lacks phytate. The...
Insilico Medicine Welcomes Dr. Halle Zhang as New Vice President of Clinical Development for Oncology
Insilico Medicine has appointed Dr. Halle Zhang as Vice President of Clinical Development for Oncology, bringing over two decades of oncology experience from BMS and other biotech firms. Zhang will lead global clinical strategy for Insilico’s AI‑driven oncology portfolio, spanning...
FDA Grants Priority Review For Pfizer’s Marstacimab for Hemophilia A or B
The FDA granted priority review for Pfizer’s marstacimab, marketed as HYMPAVZI, to broaden its label to patients aged six and older with inhibitors and to children 6‑11 without inhibitors. Marstacimab is a weekly subcutaneous anti‑TFPI antibody, the first of its...
Navigating the Gut: The Role of Formic Acid in the Microbiome
Recent research highlights formic acid as a pivotal microbial metabolite that shapes gut ecosystem dynamics and host physiology. The study shows that specific bacterial strains generate formic acid, which modulates intestinal pH, nutrient absorption, and immune signaling. In murine models,...
Nivolumab and Ipilimumab: Key Insights From BIONIKK Study
Researchers from the phase‑2 BIONIKK trial published an exposure‑response analysis of ipilimumab and nivolumab in metastatic clear‑cell renal cell carcinoma. By correlating drug concentrations with patient outcomes, the study identified optimal dosing windows that balance efficacy with toxicity. The findings...
Neonatal Nutrition’s Impact on Body Composition
A 2026 study by Modi published in Pediatric Research demonstrates that neonatal body composition, measured with advanced techniques such as air‑displacement plethysmography, is a more informative health metric than weight alone. The research shows that specific macronutrient and human‑milk‑based feeding...
Acetylshikonin Eases Gouty Arthritis via Sirtuin1 Boost
Researchers led by Wu, C. demonstrated that acetylshikonin, a plant‑derived molecule, markedly increases SIRT1 expression in gouty arthritis models. The up‑regulation of SIRT1 coincided with significant drops in IL‑1β and TNF‑α levels, curbing joint inflammation. In parallel, the compound boosted...
STAT+: A Sign Biotech Is Back? Four Drugmakers Go Public, Raising Nearly $1 Billion in All
Four biotech firms—Agomab Therapeutics, Eikon Therapeutics, Spyglass Pharma, and Veradermics—went public this week, collectively raising close to $1 billion. A fifth company, Generate Biomedicines, filed IPO paperwork, signaling renewed confidence in public markets. The wave follows a prolonged downturn where only...
Maturing Heart-Lung Sync Reveals Preterm Infant Health
Researchers have identified cardiopulmonary phase synchronization as a robust biomarker for autonomic nervous system maturation in preterm infants. By applying Hilbert‑transform‑based signal processing to continuous ECG and respiratory waveforms, the study mapped a clear maturational trajectory that correlates with gestational...
White House’s Online Service for Drug Sales Debuts with Limited Impact on Prices
The White House launched TrumpRx, an online portal selling about 40 prescription drugs from manufacturers such as Pfizer, Eli Lilly, and Novo Nordisk at discounted rates. The platform targets cash‑pay consumers, offering "most‑favored‑nation" pricing that mirrors low overseas prices. While the service...
Simulation Finds Grass2Gas Biogas Systems May Reduce Dairy Emissions by over 20%
A Penn State-led simulation of the Grass2Gas system—combining year‑round cover crops with anaerobic digestion of manure and biomass—shows an average reduction of more than 20% in the carbon footprint of milk from a typical Pennsylvania dairy. Life‑cycle assessment reveals that...
How CDMO Alliances Can Provide End-to-End Service that Reduces Drug Development Time and Costs
Integrated CDMO networks are reshaping drug development by offering end‑to‑end expertise, especially for complex modalities such as antibody‑drug conjugates (ADCs). Partnerships between specialist CDMOs allow small and mid‑size biopharma firms to access high‑potency handling, bioconjugation, and lyophilization capabilities without building...
Researchers Uncover Novel CDK12-FOXA1 Pathway Driving Prostate Cancer Progression—Team Led by Professor Jun Pang at Sun Yat-Sen University Reveals New...
Researchers led by Jun Pang at Sun Yat‑Sen University identified a CDK12‑FOXA1 signaling axis that drives prostate cancer progression. CDK12 phosphorylates FOXA1 at serine 234, enhancing its transcriptional potency and up‑regulating MDM2, which in turn degrades the tumor‑suppressor p53. Inhibiting CDK12 with...
Hovione’s Strategy for Complexity, Speed, and Regional Supply Chains
Marcio Temtem, Hovione’s VP of Strategic Business Management, highlighted three industry shifts: growing small‑molecule complexity, faster development cycles driven by AI, and the regionalization of supply chains. Hovione counters these pressures with its amorphous solid dispersion platform, continuous flow and...
Editors Bridging Science: From Desk to Lab
The role of scientific journal editors is evolving from pure gatekeeping to active participation in laboratory research, as highlighted by Guo and Ding’s analysis in Light: Science & Applications. By immersing themselves in cutting‑edge fields such as photonics and quantum...
AI Diagnoses Cervical Spondylosis via Multimodal Imaging
Researchers led by Song, Li, and Ouyang introduced a multi‑task deep‑learning model that simultaneously analyzes MRI, CT and X‑ray scans to diagnose cervical spondylosis. Trained on thousands of annotated multimodal images, the system captures bony, disc and neural pathologies with...
UniQure Pauses Higher Doses in Fabry Study; Aro Shares Pompe Data
UniQure announced a pause on the mid‑ and high‑dose cohorts of its Fabry disease gene‑therapy trial after two participants receiving 4×10^13 genome copies per kilogram experienced safety concerns. The low‑dose arm will continue while the company conducts a detailed safety...
